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Abstract
Background and Purpose: Many stroke trials include maximal inspiratory pressure
(MIP), maximal expiratory pressure (MEP), and sniff nasal inspiratory pressure
(SNIP) outcome measurements. However, data on agreement and reliability of
repeated MIP, MEP, and SNIP measurements in acute and subacute stroke patients
are scarce.
Methods: This study employed a test–retest design. Eighteen patients (seven fe-
male) with mean (SD) age 59 (14.5) years were recruited from neurological wards.
Median (range) time since first stroke was 50.5 (21–128) days. MIP, MEP, and SNIP
were measured repeatedly in three testing sessions (S1–3) conducted within 24 h
and following international standards. Intra‐rater agreement between testing ses-
sions was analyzed using the Bland–Altman method. Test–retest reliability was
analyzed using intra‐class correlation coefficient (ICC). Association between indi-
vidual measurement variability, time poststroke, and level of stroke impairment was
analyzed using Spearman's rho.
Results: Mean difference and 95% limits of agreement for MIP were −0.40 (−23.02,
22.22) cmH2O between S1 and S2, and 2.14 (−12.79, 16.99) cmH2O between S2
and S3; for MEP, −4.56 (−29.01, 19.90) cmH2O between S1 and S2, and 0.29
(−24.28, 24.87) cmH2O between S2 and S3; and for SNIP, −10.56 (−38.48, 17.37)
cmH2O between S1 and S2, and −6.06 (−27.32, 15.20) cmH2O between S2 and S3.
ICCs for MIP, MEP, and SNIP were ≥0.9 throughout. There were no strong corre-
lations between individual measurement variability and time poststroke or level of
stroke impairment.
Discussion: MIP, MEP, and SNIP in acute and subacute stroke patients show good
test–retest reliability for group averages; however, absolute agreement can vary
considerably for some individuals.
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1 | INTRODUCTION
It is well‐established that stroke can lead to significant and lasting
respiratory muscle weakness (Harraf et al., 2008; Luvizutto
et al., 2017; Pollock, Rafferty, Moxham, & Kalra, 2013; Ward
et al., 2010). This may in turn impact on stroke survivors' respiratory
function and cough effectiveness (Ward et al., 2010, 2017), cardio-
respiratory endurance (Lista Paz et al., 2016), and performance of
daily activities (Kulnik, 2015a; Xiao, Luo, Wang, & Luo, 2012). In
recent years, investigators have increasingly targeted stroke‐related
respiratory muscle impairment, by trialing various respiratory
training methods based on differing underlying rationales and with
various hypothesized patient benefits and outcomes (Gomes‐Neto
et al., 2016; Martin‐Valero, De La Casa Almeida, Casuso‐Holgado, &
Heredia‐Madrazo, 2015; Menezes, Nascimento, Avelino, Alvarenga, &
Teixeira‐Salmela, 2016, 2018; Xiao et al., 2012). Patient assessments
in these stroke trials often include mouth pressure measurements,
that is, maximal inspiratory pressure (MIP), maximal expiratory
pressure (MEP), and sniff nasal inspiratory pressure (SNIP). These
measurements are taken noninvasively and can be performed
conveniently at the patient bedside in any clinical or community
setting (Laveneziana et al., 2019). The validity of MIP, MEP, and SNIP
measurements as indicators of respiratory muscle function (or
impairment) has been established in detailed physiological studies of
acute stroke patients and matched healthy control participants
(Harraf et al., 2008; Ward et al., 2010) and in observational studies of
chronic stroke survivors with differing levels of physical ability (e.g.,
Pinheiro et al., 2014). Longitudinal MIP and MEP measurements
are often required to adjust the intensity of respiratory muscle
training to individuals' baseline levels and any incremental improve-
ments during the training period (McConnell, 2013). In stroke trials,
MIP, MEP, and SNIP data are often collected longitudinally as in-
dicators of change in respiratory muscle strength over time, or even
as the primary outcome (e.g., Parreiras de Menezes et al., 2019).
Longitudinal measurements require an understanding of agree-
ment between repeated tests, so that differences can be compared
againstexpectedmeasurementvariability intheabsenceofchange.This
allows a judgement on whether differences in repeated measurements
are likely to represent true change, or whether differences may lie
within the range of expected measurement variability (Hernaez, 2015;
de Vet, Terwee, Knol, & Bouter, 2006; Domholdt, 2005; Taylor, 1997).
Surprisingly, while many stroke investigators have included repeated
measurements of MIP, MEP, and SNIP in their studies, published data
on agreement of these measurements in stroke patients are scarce.
Consistency in these repeated measurements principally relies
on the test subject acquiring the correct technique and exerting a
consistent maximal volitional effort (Laveneziana et al., 2019;
American Thoracic Society/European Respiratory Society, 2002).
Stroke survivors can often exhibit fluctuations in alertness, cognition,
fatigue, and co‐ordination, but also pronounced learning effects over
short time periods, particularly during the acute and subacute phases
poststroke. This may disproportionally affect agreement of repeated
measurements. It is, therefore, important to examine agreement in
this patient group, so that longitudinal data can be interpreted in the
context of expected variability and minimal detectable difference. In
addition, reliability is important when groups of individuals are being
assessed. Reliability refers to the ability of a measurement to detect
“real” variability between subjects, and it has been recommended
that studies examining measurement properties should report both
agreement and reliability (Hernaez, 2015).
The primary aim of this study was to examine agreement and
reliability of repeated MIP, MEP, and SNIP measurements in acute
and subacute stroke patients. The secondary aim was to examine
whether measurement variability might be related to stroke impair-
ment, by evaluating associations between agreement and stroke‐
related neurological and functional impairment.
2 | METHODS
2.1 | Study design
A test–retest design was used to evaluate agreement and reliability
of three respiratory muscle measures (MIP, MEP, and SNIP). The
study was approved by the bio‐ethical committee of the Institute of
Psychiatry and Neurology, Warsaw, Poland (reference number 29/
2015).
2.2 | Subjects
Patients up to 5 months after first‐ever stroke were recruited from
neurological wards at the study site. Data were collected from
September 2015 to June 2018. Inclusion criteria were cognitive
ability to follow the test instructions and informed consent. Exclusion
criteria were National Institutes of Health Stroke Scale (NIHSS) score
<5, blood pressure >180/100 mmHg, recent acute cardiac episode,
and co‐existing chronic conditions affecting lung function (such as
respiratory disease, neurological disorders, or chest wall deformities).
All participants provided written informed consent.
2.3 | Materials
The Micro Respiratory Pressure Meter (RPM; Micro Medical) was
used to measure maximal mouth pressures. The device was cali-
brated by the manufacturer. Spirometry was measured using the
MicroLoop spirometer (Micro Medical). The spirometer was cali-
brated using a 3 L syringe as per manufacturer recommendation.
2.4 | Procedure
All patients attended three assessment sessions (S1, S2, and S3)
within 24 h with at least 2 h between sessions. Spirometry was
assessed at the beginning of S1. Assessments were performed before,
or at least 1 h after meals. In each session, patients performed MIP,
MEP, and SNIP maneuvers according to American Thoracic Society/
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European Respiratory Society recommendations (2002). A minimum
of 10 efforts were made until reaching the maximum value of three
maneuvers that varied by less than 20%. The highest value was used
for analysis. Patients were given at least 30 s rest between efforts.
Individual feedback and strong verbal encouragement were given
throughout. Each patient was assessed by the same trained investi-
gator (A.L. or M.S.) in all three sessions. Figure 1 presents the
assessment sequence.
2.5 | Maximum inspiratory/expiratory pressure
MIP was assessed from residual volume and MEP from total lung
capacity using the inspiratory and expiratory pressure valve assem-
bly, respectively. Bacterial filters were applied to prevent cross
contamination between users. For optimal lip seal, a sterilized rub-
ber‐flanged mouthpiece was used. Patients were seated upright,
wore nose clips, and were encouraged to make maximal inspiratory
or expiratory efforts sustained for 1 s.
2.6 | Sniff nasal inspiratory pressure
SNIP tests were performed from functional residual capacity (FRC)
with patients in the sitting position. Manufacturer's nasal probes in
three sizes (small, medium, or large) were used together with the
nasal probe adapter. The size of the probe was chosen to best fit
individuals' left nostril. Patients were asked to perform a strong,
sharp sniff with encouragement from the investigator.
2.7 | Lung function
Baseline spirometry was measured according to American Thoracic
Society/European Respiratory Society standards (Miller et al., 2005),
and repeated measurements were taken until 10% variation between
three efforts was achieved. Best results for forced expiratory volume
in one second (FEV1) and forced vital capacity were recorded as
actual and percent predicted values.
2.8 | Baseline characteristics and stroke‐related
impairment
The following participant characteristics were recorded from hospital
medical records: age, sex, height, body mass index, time since stroke,
stroke etiology, and lesion site. Stroke‐related impairment was
measured using the NIHSS (Goldstein, Bertels, & Davis, 1989),
Modified Rankin Scale (Banks & Marotta, 2007), Barthel Index (BI;
Mahoney & Barthel, 1965), Rivermead Motor Assessment Scale
(MAS) consisting of three subscales Gross Function, Arm (A), and Leg
and Trunk (Carr, Shepherd, Nordholm, & Lynne, 1985), and the Trunk
Impairment Scale (TIS; Verheyden et al., 2004).
2.9 | Sample size calculation
A sample size calculation was based on data from repeated MIP and
MEP measurements in subacute stroke patients (Kulnik, 2015b).
Assuming an intra‐class correlation coefficient (ICC) of 0.90, the
sample size required to estimate this parameter with the precision of
a 95% confidence interval (CI) of ±0.1 was 12 subjects
(Bonett, 2002). Accounting for a conservative estimate of 33%
attrition, the target sample size for this study was 18.
2.10 | Data analysis
Participant characteristics were summarized using descriptive sta-
tistics. To examine agreement, the differences in measurements be-
tween subsequent testing sessions (S1–S2, S2–S3) were calculated.
Differences were summarized using descriptive statistics and
examined for normal distribution using histograms, Kolmogorov–
Smirnov and Shapiro–Wilk tests. The method by Bland and Alt-
man (1999) was used to describe mean differences and 95% limits of
agreement between subsequent testing sessions, including visuali-
zation in Bland–Altman plots. Upper and lower 95% limits of agree-
ment were calculated by mean difference ±1.96 � standard deviation
(SD) of the differences (Bland & Altman, 1999). Systematic mea-
surement bias was assessed through linear regression of the differ-
ence between two measurements on the mean of two measurements.
Reliability was evaluated using an ICC with 95% CI for two
consecutive measurements. The type of ICC was selected according
to the relevant assumptions (Hernaez, 2015), that is, using a random
effects model, comparing absolute agreement, and comparing indi-
vidual measurements. The standard error of measurement (SEM) was
calculated as SD of mean differences/√2 (de Vet et al., 2006,
p. 1037). The smallest detectable change (also termed minimal
detectable change/difference) was calculated as 1.96 � √2 � SEM
(de Vet et al., 2006, p. 1038).
To examine associations between variability in agreement of
repeated MIP, MEP, and SNIP and stroke‐related neurological and
functional impairment, the range of measurements across all three
testing sessions was calculated for all measures, indicating the
magnitude of variability in measurements for each individual subject.
Associations between the magnitude of variability and measures of
stroke impairment (time since stroke, NIHSS, BI, Rivermead MAS, and
TIS) were assessed using nonparametric correlation (Spearman’s rho).
All analyses were conducted in SPSS 24 (IBM, 2018).
3 | RESULTS
3.1 | Participants
Summary for participant characteristics is presented in Table 1. Data
for MIP, MEP, and SNIP are presented in Table 2. All participants
were naive to the investigation.
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3.2 | Agreement of repeated measurements
Mean (SD) differences and 95% limits of agreement are presented in
Table 3. The distribution was sufficiently normal. Bland–Altman plots
for MIP, MEP, and SNIP are given in Figures 2–4, respectively.
Assessment of systematic bias showed a statistically significant result
only for agreement in MIP between S1 and S2 (coefficient 0.192,
p = 0.023), but not for the remaining comparisons.
3.3 | Reliability of repeated measurements
ICCs, SEM, and smallest detectable change for repeated MIP, MEP,
and SNIP are presented in Table 4.
3.4 | Associations between variability in agreement
and stroke‐related impairment
Correlation coefficients ranged from −0.487 to 0.439, indicating
weak‐to‐moderate correlations. Correlations were nonsignificant,
except for the correlation between variability in SNIP and the Arm
component sub‐score of the Rivermead MAS (Spearman's rho
−0.487, p = 0.047). The correlation matrix and statistical significance
levels are presented in Table 5.
4 | DISCUSSION
This study has provided data to estimate test–retest agreement and
reliability of MIP, MEP, and SNIP during the acute and subacute
phases of stroke. Agreement for MIP and MEP showed small mean
differences, with 95% limits of agreement spanning 30–50 cmH2O.
Agreement for SNIP showed larger mean differences and 95% limits
of agreement spanning up to 55 cmH2O. Reliability for MIP, MEP,
and SNIP was very high, with ICCs ≥0.90 and narrow 95% CIs
throughout. Agreement and reliability improved for all three mea-
sures from S1–S2 to S2–S3, indicating improved consistency in test
performance with increasing number of repetitions. This could be an
indication of learning effect due to test familiarization. Individual
variability in measurements was not explained by time since stroke
or measures of stroke impairment (NIHSS, BI, Rivermead MAS, and
TIS). Only the Arm subscale of the Rivermead MAS showed a mod-
erate statistically significant correlation with measurement vari-
ability, and this correlation would lose statistical significance if
adjusted for multiple testing.
Test–retest reliability of MIP, MEP, and SNIP has been investi-
gated in healthy subjects (Dimitriadis, Kapreli, Konstantinidou, Old-
ham, & Strimpakos, 2011; Maillard, Burdet, van Melle, &
Fitting, 1998) and patients with respiratory conditions (Larson
et al., 1993; Nikoletou et al., 2014). ICCs for MEP and MIP in healthy
subjects have been reported as 0.88 and 0.90, respectively (Dimi-
triadis et al., 2011). In patients with COPD, test–retest reliability for
all three measures showed good reliability, with ICCs of 0.89 for MIP,
0.96 for MEP, and 0.94 for SNIP (Larson et al., 1993; Nikoletou
et al., 2014). While these ICCs are overall comparable to our results,
SNIP in patients with COPD showed somewhat better reliability than
MIP, which is contrary to our findings in stroke patients.
Published data on agreement and reliability of MIP, MEP, and
SNIP in stroke patients are scarce, but there have been studies in
other neurological patient groups. Repeatability of SNIP measure-
ments was investigated in patients with various neuromuscular
nonstroke conditions and lung diseases (Lofaso et al., 2006). There
was a significant difference between the first and second session, but
only a marginal improvement after 20 maneuvers. Bland–Altman
analysis demonstrated a mean between‐session difference of
3.5 ± 7.7 cmH2O. Although our study also demonstrated improve-
ment after the first session, indicating similar learning effect, the
mean difference for SNIP was larger, which may be due to differences
in testing protocols.
Intra‐rater reliability of MIP and MEP between four testing
sessions has been investigated in multiple sclerosis (Smeltzer &
Lavietes, 1999). The results indicated that two practice sessions were
needed for each measure. Test–retest reliability was also tested for
patients with Huntington's (Reyes, Cruickshank, Ziman, &
Nosaka, 2014) and Parkinson's disease (Reyes, Castillo, Castillo, &
F I GUR E 1 Assessment session schedule (S1, S2, S3—Session 1, 2, 3; MIP, maximal inspiratory pressure; MEP, maximal expiratory
pressure; SNIP, sniff nasal inspiratory pressure)
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Cornejo, 2018). Although reliability for both MIP and MEP between
three sessions was good for patients with Huntington's disease (ICCs
of 0.94 and 0.92, respectively), it showed greater variability than a
healthy control group (Reyes et al., 2014). The results for patients
with Parkinson's disease also showed acceptable reliability (ICCs of
0.95 and 0.92, respectively), but there were significant differences
between the first and second session (Reyes et al., 2018). Addition-
ally, these studies indicate learning effects in the performance of
these tests, which are similar to our results and in line with studies in
healthy volunteers and in respiratory patients; however, detailed
comparisons between studies are difficult due to differing testing
protocols and data analysis methods.
TAB L E 1 Participant characteristics
Participant characteristics Sample (n = 18)
Age (years) 59 (14.5)
Sex Female 7 (38.9%)
Male 11 (61.1%)
Height (cm) 175.9 (10.0)
Body mass index 27.4 (5.1)
Time since stroke (days) 50.5 (21–128)
Stroke etiology Ischemic 12 (66.7%)
Hemorrhagic 6 (33.3%)
Stroke site Cortical 10 (55.6%)
Subcortical 5 (27.8%)
Brainstem 3 (16.7%)
Stroke side Left 9 (50.5%)
Right 8 (44.4%)
Bilateral 1 (5.6%)
NIHSS (0–42)a 7.4 (2.1)
Modified Rankin Scale (0–5)a 3—Moderate disability 8 (44.4%)
4—Moderately severe disability 8 (44.4%)
5—Severe disability 2 (11.1%)
Barthel Index (0–20)b 9.2 (5.1)
Rivermead MAS—Gross Function (0–13)b 6.4 (3.3)
Rivermead MAS—Leg and Trunk (0–10)b 4.8 (2.1)
Rivermead MAS—Arm (0–15)b 2.4 (3.1)
Rivermead MAS—Combined score (0–38)b 13.5 (6.8)
Trunk Impairment Scale (0–23)b 13.9 (4.2)
Respiratory function FEV1 (L) 2.1 (0.8)
FEV1 % predicted 88.2 (12.2)
FVC (L) 3.5 (1.0)
FVC % predicted 87.6 (14.6)
FEV1/FVC ratio 0.82 (0.07)
MIP predicted (cmH2O) 105.8 (42.5)
MEP predicted (cmH2O) 99.8 (27.9)
Note: Values are mean (SD), median (range), or frequencies (percentages).
Abbreviations: FEV1, forced expiratory volume in one second; FVC, forced vital capacity; MAS,
Motor Assessment Scale; MEP, maximal expiratory mouth pressure; MIP, maximal inspiratory mouth
pressure; NIHSS, National Institutes of Health Stroke Scale.
aHigher scores indicate greater stroke‐related impairment or disability.
bHigher scores indicate better function or performance.
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Repeated outcome measurement can affect the internal validity
of a longitudinal study, when an observed change reflects familiar-
ization with the testing procedure, rather than “true” change in the
underlying body function (Domholdt, 2005). This concern has been
previously raised with respect to studies of respiratory muscle
training interventions (Polkey & Moxham, 2004). A strategy to con-
trol for test familiarization is the inclusion of a control group, which
completes all assessment procedures in the same way as the inter-
vention group (Domholdt, 2005). Alternatively, in a controlled study
design, it is possible to conduct a postintervention test only. The
latter removes the aspect of repeated testing and test familiarization
but also eliminates the possibility of comparing outcome parameters
between study groups at baseline. Some study designs include an
initial test familiarization period to achieve stable repeat test per-
formances before the intervention is introduced. This strategy is
suitable for assessments, which rely on participants acquiring the
correct technique and exerting a maximal volitional effort such as
maximal strength tests (Phillips, Batterham, Valenzuela, & Bur-
kett, 2004; Phillips, Benton, Wagner, & Riley, 2006). It is perhaps
more straightforward to achieve test familiarization in populations,
which are stable within their condition and able to attend
familiarization sessions over several days or weeks. Our study dem-
onstrates that it is possible to incorporate repeated assessments of
MIP, MEP, and SNIP within 24 h at the beginning of a study in acute
and subacute stroke. Even if in this short time period, stable test
performance cannot be achieved, this at least gives an indication of
individual subjects' test–retest variability to inform the interpreta-
tion of observed change in measurements, or to be incorporated in a
statistical analysis model. Since our data at group level describe
relatively large values for the smallest detectable change in this pa-
tient population, ranging from 15 to 28 cmH2O (Table 4), methods
which take into account smallest detectable change at individual
patient level could potentially add value to the analysis of respiratory
muscle training trials in stroke.
Lastly, putting the magnitude of an observed change into
context, the minimal (clinically) important difference (MID/MCID)
may be described. It is noteworthy that, to our knowledge, MID has
not been reported for SNIP or MEP, and we are unable to interpret
the clinical relevance of differences in repeated tests for these
measures. There is literature describing reference values for MIP,
MEP, and SNIP in the general population (Laveneziana et al., 2019),
and an individual's measurements may be compared with the range
TAB L E 2 Repeated MIP, MEP, and SNIP measurements at three time points (S1, S2, and S3)
Participant number
MIP (cmH2O) MEP (cmH2O) SNIP (cmH2O)
S1 S2 S3 S1 S2 S3 S1 S2 S3
1 58 51 a 80 81 a 49 52 a
2 72 70 71 84 95 99 81 86 105
3 32 42 38 50 52 50 27 23 28
4 31 41 32 36 71 40 12 24 19
5 75 67 85 145 138 138 53 56 70
6 b b b 80 115 112 75 96 93
7 33 b b 101 96 84 43 55 73
8 60 60 57 115 113 112 39 42 47
9 131 117 121 100 110 111 74 73 96
10 108 108 105 117 124 124 119 142 142
11 b b b 56 46 50 47 53 42
12 74 72 67 135 135 135 82 82 70
13 63 61 57 61 61 92 25 45 64
14 138 119 121 161 160 152 148 132 146
15 82 94 93 121 121 122 88 124 121
16 93 93 77 111 115 132 73 75 84
17 24 53 49 131 125 118 57 93 103
18 148 147 141 159 167 168 123 152 153
Sample mean (SD) 76.4 (38.9) 79.7 (31.8) 79.6 (33.1) 102.4 (37.2) 106.9 (34.5) 108.2 (35.9) 67.5 (36.9) 78.1 (39.7) 85.7 (40.1)
Note: S1, S2, and S3 denote testing sessions 1, 2, and 3.
Abbreviations: MEP, maximal expiratory pressure; MIP, maximal inspiratory pressure; SNIP, sniff nasal inspiratory pressure.
aParticipant declined assessment session S3.
bParticipant unable to perform the measurement.
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of norm values for a person of the same sex and age; although to our
knowledge there has not been any research to validate this approach
in the stroke population. A small number of studies have described
MID for MIP in people with COPD, indicating clinically relevant
improvements of 13 cmH2O (Gosselink et al., 2011) and a distribu-
tion‐based MID of approximately 17 cmH2O (Iwakura et al., 2020). In
our study, the smallest detectable change for MIP from S1 to S2 was
greater than these MID values, while for MIP from S2 to S3, it was

























S1–S2 (n = 15) −0.40 11.54 −6.79 to 5.99 22.22 11.29 to 33.15 −23.02 −33.95 to −12.09
S2–S3 (n = 14) 2.14 7.57 −2.23 to 6.52 16.99 9.53 to 24.45 −12.70 −20.16 to −5.24
MEP
(cmH2O)
S1–S2 (n = 18) −4.56 12.48 −10.76 to 1.65 19.90 9.29 to 30.51 −29.01 −39.62 to −18.40
S2–S3 (n = 17) 0.29 12.54 −6.15 to 6.74 24.87 13.85 to 35.89 −24.28 −35.30 to −13.26
SNIP
(cmH2O)
S1–S2 (n = 18) −10.56 14.25 −17.64 to −3.47 17.37 5.25 to 29.49 −38.48 −50.60 to −26.36
S2–S3 (n = 17) −6.06 10.85 −11.64 to −0.48 15.20 5.67 to 24.73 −27.32 −36.85 to −17.79
Note: S1, S2, and S3 denote testing sessions 1, 2, and 3.
Abbreviation: MEP, maximal expiratory pressure; MIP, maximal inspiratory pressure; SNIP, sniff nasal inspiratory pressure.
aUpper and lower limits of agreement = mean difference ± 1.96 � SD of differences (Bland & Altman, 1999).
TAB L E 4 Intraclass correlation coefficients, standard error of measurement, and smallest detectable change for repeated MIP, MEP, and
SNIP measurements
Measure ICCa 95% Confidence interval of ICC SEMb Smallest detectable changec
MIP S1, S2 (n = 15) 0.950 0.857 to 0.983 8.16 22.62
S2, S3 (n = 14) 0.973 0.920 to 0.991 5.35 14.84
MEP S1, S2 (n = 18) 0.935 0.835 to 0.975 8.82 24.46
S2, S3 (n = 17) 0.941 0.844 to 0.978 8.87 24.58
SNIP S1, S2 (n = 18) 0.896 0.611 to 0.966 10.08 27.93
S2, S3 (n = 17) 0.954 0.854 to 0.984 7.67 21.27
Note: S1, S2, and S3 denote testing sessions 1, 2, and 3.
Abbreviations: ICC, intra‐class correlation coefficient; MEP, maximal expiratory pressure; MIP, maximal inspiratory pressure; SEM, standard error of
measurement; SNIP, sniff nasal inspiratory pressure.
aRandom effects model for comparison of absolute agreement and individual measurements.
bStandard deviation of mean differences/√2 (de Vet et al., 2006, p. 1037).
c1.96 � √2 � SEM (de Vet et al., 2006, p. 1038).
TAB L E 5 Correlation matrix for associations between variability in agreement (range of three repeated measurements) and stroke‐
related impairment. Shown are Spearman's rho and statistical significance level








































































Abbreviations: MAS, Motor Assessment Scale; MEP, maximal expiratory pressure; MIP, maximal inspiratory pressure; NIHSS, National Institutes of
Health Stroke Scale; SNIP, sniff nasal inspiratory pressure.
LEWKO ET AL. - 7 of 11
similar in magnitude (Table 4). However, as there are no studies to
indicate MID/MCID for MIP, MEP, or SNIP in stroke populations,
these reference values should be interpreted with caution.
4.1 | Strengths and limitations of the study
A study strength was the experience of the investigators in clinical
measurement, giving confidence that patients were instructed, and
tests performed according to the relevant standards. Stroke may
affect individuals' cognitive function or coordination, which can lead
to difficulties in performing specific respiratory maneuvers. In our
study, we could see that three patients struggled with performing the
MIP maneuver but were able to adequately perform MEP and SNIP.
This underscores the importance of the investigator providing
adequate guidance and support to patients, so that their performance
of MIP, MEP, and SNIP maneuvers meets requirements, and recog-
nizing when a patient's difficulties invalidate these measurements
(Laveneziana et al., 2019). Another strength was that repeated
measurements were conducted within 24 h, so that measurement
F I GUR E 2 Agreement of repeated maximal inspiratory mouth pressure (MIP) measurements between first (S1) and second (S2) testing
session, and between second (S2) and third (S3) testing session. Solid lines indicate the lines of equality (no difference between measurements).
Three dashed lines indicate the mean difference between measurements (bias) and the upper and lower 95% limits of agreement
(bias ± 1.96 � SD)
F I GUR E 3 Agreement of repeated maximal expiratory mouth pressure (MEP) measurements between first (S1) and second (S2) testing
session, and between second (S2) and third (S3) testing session. Solid lines indicate the lines of equality (no difference between measurements).
Three dashed lines indicate the mean difference between measurements (bias) and the upper and lower 95% limits of agreement
(bias ± 1.96 � SD)
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variability is likely to represent factors other than recovery from
stroke, for example, diurnal fluctuations in fatigue, attention/con-
centration, and motivation. Data analysis was comprehensive, using
both reliability (ICC) and Bland–Altman analyses. The latter identify
individual variability and ‐ importantly ‐ allow an appreciation of
measurement variability in the unit of measurement.
The study was limited in that data represent intrarater but not
inter‐rater agreement and reliability. Investigators employing several
assessors for repeated measurements of any one participant are
advised to establish study‐specific reference values for inter‐rater
agreement and reliability. It is acknowledged that spirometry, which
was conducted at the beginning of testing session S1 but not in
sessions S2 and S3, introduced added demand on participants' res-
piratory muscles in S1. While our data do not indicate that this may
have led to systematically lower readings of MIP, MEP, and SNIP at
S1 (e.g., due to spirometry causing respiratory muscle fatigue), it is
acknowledged that a protocol with three identical testing sessions
S1–S3 would be preferable. Lastly, the study was powered to achieve
a certain level of precision of the ICC. CIs for bias and limits of
agreement in Bland–Altman analyses were relatively wide, spanning
between 9 and 24 cmH2O. It may be warranted to replicate this
study with a sample size powered to achieve greater precision in
limits of agreement and methods for estimating required sample sizes
for this have been described (Lu et al., 2016).
5 | CONCLUSION
In conclusion, this study has demonstrated that repeated measure-
ments of MIP, MEP, and SNIP in the acute and subacute phases of
stroke show consistent group averages and variances, and good
test–retest reliability. However, in some participants, there were
considerable discrepancies in absolute agreement of up to 23, 29, and
38 cmH2O for MIP, MEP, and SNIP, respectively. The magnitude of
these discrepancies was not correlated with time since stroke or with
measures of stroke‐related impairment, leading us to conclude that
test–retest variability should be considered across stroke populations,
and individually assessed to inform interpretation of change over time.
6 | IMPLICATIONS FOR PHYSIOTHERAPY
PRACTICE
It is feasible to conduct repeated measurements of MIP, MEP, and
SNIP during the acute and subacute phases of stroke. It may be
recommended that investigators incorporate repeated baseline
measurements of MIP, MEP, and SNIP into study designs, to establish
study‐specific intra‐ and inter‐rater reliability, and to identify in-
dividuals with high variability of repeated measurements. This will
facilitate the interpretation of (change in) longitudinal measurements
in the context of expected variability and minimal detectable
difference.
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F I GUR E 4 Agreement of repeated sniff nasal inspiratory pressure (SNIP) measurements between first (S1) and second (S2) testing session,
and between second (S2) and third (S3) testing session. Solid lines indicate the lines of equality (no difference between measurements). Three
dashed lines indicate the mean difference between measurements (bias) and the upper and lower 95% limits of agreement (bias ± 1.96 � SD)
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